微波辅助水解-HPAEC-PAD同时定量人血清唾液酸及六种聚糖单糖:RSM优化、验证及急性卒中概念验证
该研究开发了一种无需衍生的方法,采用微波辅助三氟乙酸水解结合HPAEC-PAD同时定量人血清中七种单糖(含不稳定的唾液酸)。通过单因素实验和响应面法确定最佳水解条件为105°C、30分钟、1.37 M TFA,方法在10 μL空腹血清上验证,重现性良好(峰面积RSD<5%,n=4)。在卒中队列中(47例AIS、50例ICH、51例健康对照)证实单糖谱差异,唾液酸和岩藻糖在AIS和ICH中均升高但AIS更显著,甘露糖与MRI梗死体积相关(R2=0.543,P=0.003),而70项常规实验室检查均无法区分AIS与ICH。
要点
- 微波辅助TFA水解-HPAEC-PAD可同时定量血清中七种单糖,仅需10 μL血清。
- 最佳水解条件为105°C、30分钟、1.37 M TFA,峰面积RSD<5%(n=4)。
- 血清甘露糖与MRI梗死体积相关(R2=0.543,P=0.003),常规检查无法区分AIS与ICH。
核心结论
- 该微体积高通量平台可同时定量血清中七种单糖,并在卒中队列中显示单糖谱差异,甘露糖与梗死体积相关。
研究设计与样本
- 方法开发与验证研究,采用单因素实验和响应面法优化水解条件,在10 μL空腹血清上验证方法。
- 概念验证应用于临床卒中队列,包括47例急性缺血性卒中、50例脑出血和51例匹配健康对照。
- 回顾性分析70项常规实验室检查以评估其区分AIS与ICH的能力。
主要发现
- 最佳水解条件为105°C、30分钟、1.37 M TFA,可有效释放岩藻糖、半乳糖胺、葡萄糖胺、半乳糖、葡萄糖和甘露糖,同时限制唾液酸损失。
- 峰面积RSD<5%(n=4),色谱分离可分辨所有七种单糖,半乳糖、葡萄糖和甘露糖间接近基线分离但部分共洗脱。
- 唾液酸和岩藻糖在AIS和ICH中均高于健康对照,但AIS中升高更显著;半乳糖、甘露糖和葡萄糖胺在两种卒中亚型中均升高。
- 血清甘露糖与MRI定义的梗死体积相关(R2=0.543,P=0.003)。
- 回顾性分析70项常规实验室检查均无法区分AIS与ICH。
关键数值与推荐
- 水解条件:105°C、30分钟、1.37 M TFA。
- 重现性:峰面积RSD<5%(n=4)。
- 甘露糖与梗死体积相关性:R2=0.543,P=0.003。
- 队列样本量:47例AIS、50例ICH、51例健康对照;常规检查回顾分析70项。
临床怎么用
- 该微体积高通量平台可用于临床化学和生物标志物研究,为下游多变量糖组学分析提供基础。
- 血清单糖谱(尤其是唾液酸、岩藻糖和甘露糖)可能有助于卒中分型及梗死体积评估,但需进一步验证。
局限性
- 半乳糖、葡萄糖和甘露糖之间存在部分共洗脱。
- 概念验证队列样本量有限,需更大规模研究验证。
- 常规实验室检查回顾性分析未能区分AIS与ICH,提示需要更特异的标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A derivatization-free method for the simultaneous quantification of seven monosaccharides, including the labile sialic acid, in human serum was developed using microwave-assisted trifluoroacetic acid (TFA) hydrolysis coupled with high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Single-factor experiments and Response Surface Methodology (RSM) identified optimal hydrolysis conditions of 105 °C, 30 min, and 1.37 M TFA. These parameters achieved efficient release of fucose, galactosamine, glucosamine, galactose, glucose, and mannose while limiting loss of the labile sialic acid. The method was characterized on 10 μL fasting serum using a CarboPac PA10 column (30 °C) with a sodium acetate/sodium hydroxide gradient and quadruple-potential PAD waveform. Reproducibility was good (peak-area RSD < 5%, n = 4). Chromatographic separation resolved all seven monosaccharides, with near-baseline resolution and partial co-elution among galactose, glucose, and mannose. Proof-of-concept application to a clinical stroke cohort (47 acute ischaemic stroke [AIS], 50 intracerebral haemorrhage [ICH], and 51 matched healthy controls) confirmed distinct monosaccharide profiles: sialic acid and fucose were elevated in both AIS and ICH relative to healthy controls but disproportionately greater in AIS, while galactose, mannose, and glucosamine were elevated in both stroke subtypes. Serum mannose correlated with MRI-defined infarct volume (R2 = 0.543, P = 0.003), and retrospective analysis of 70 conventional laboratory tests confirmed that none differentiated AIS from ICH. This micro-volume, high-throughput platform overcomes longstanding limitations of existing glycan analysis methods and provides a promising basis for clinical chemistry and biomarker studies and a substrate for downstream multivariate glycomic analyses.
引用
- Zhang M, Zhang L, Lu H, et al. Microwave-assisted hydrolysis and HPAEC-PAD for simultaneous quantification of sialic acid and six other glycan monosaccharides in human serum: RSM optimization, validation, and proof-of-concept application to acute stroke. Clin Chim Acta. 2026. PMID: 42521007. doi:10.1016/j.cca.2026.121251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。